ELAB — Elevai Labs, Inc. Common Stock · rev $2.0M

Elevai Labs, Inc. Common Stock (ELAB) is a biotechnology company listed on NASDAQ.

Latest reported ELAB revenue for 2026-06-30 was $2.0M. Net income was -$7.9M. ELAB currently screens at market cap $6.5M.

Use this ELAB page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ELAB quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ELAB SEC filings page. Lician reads the product cache first so this HTML stays unique to Elevai Labs, Inc. Common Stock even when a live quote feed is slow.